Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

• Status: Completed
• Trial end date: 2016-12-21
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Servier Hellas Pharmaceuticals Ltd.
• Treatments: Amlodipine; Indapamide; Perindopril

Criteria

Inclusion Criteria:

• Male or female, ambulatory patients >18 years old.

• Clinically diagnosed essential arterial hypertension.

• Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.

• The patient has given his/her written consent after being informed, before his inclusion in the study.

Exclusion Criteria:

• Secondary arterial hypertension.

• Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event with serious residual lesions, scheduled procedure or surgical operation or hospital admission.

• Pregnancy, lactation or intention to become pregnant.